Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-α or IFN-γ

Digestive and Liver Disease

Volumn 38, Issue 8, 2006, Pages 563-577

  Zocco, M A ^a,b   Carloni, E ^a   Pescatori, M ^a   Saulnier, N ^a   Lupascu, A ^a   Nista, E C ^a   Novi, M ^a   Candelli, M ^a   Cimica, V ^b   Mihm, S ^b   Gasbarrini, G ^a   Ramadori, G ^b   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cellular pathways; Cytokines; Immune response; Macrophages; Microarray

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GROWTH FACTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; KUPFFER CELL; MACROPHAGE ACTIVATION; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; BIOLOGICAL RESPONSE MODIFIERS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-GAMMA; KUPFFER CELLS; MACROPHAGE ACTIVATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTOSIS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 33748488664     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.04.015     Document Type: Article

References (41)

1. Jones E.A., and Summerfield J.A. Kupffer cells. In: Arias I.M., Jakoby W.B., Popper H., Schachter D., and Shafritz D.A. (Eds). The liver: biology and pathobiology (1998), Raven Press, New York 683-704
2. Armbrust T., and Ramadori G. Functional characterization of two different Kupffer cells populations of normal rat liver. J Hepatol 25 (1996) 518-525
3. Toth C.A., and Thomas P. Liver endocytosis and Kupffer cells. Hepatology 16 (1992) 255-266
4. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192 (1990) 245-261
5. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
6. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 14 (2001) 778-809
7. Brassard D.L., Grace M.J., and Bordens R.W. Interferon-α as an immunotherapeutic protein. J Leukoc Biol 71 (2002) 565-581
8. Vadiveloo P.K., Vairo G., Hertzog P., Kola I., and Hamilton J.A. Role of type I interferons during macrophage activation by lipopolysaccharide. Cytokine 12 (2000) 1639-1646
9. Ramadori G., and Saile B. Inflammation, damage repair, immune cells and liver fibrosis: specific or non-specific, this is the question. Gastoenterology 127 (2004) 997-999
10. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163-189
11. Presti R.M., Popkin D.L., Connick M., Paetzold S., and Virgin H.W. Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages. J Exp Med 193 (2001) 483-496
12. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., and Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 284 (1999) 825-829
13. Thimme R., Bukh J., Spangenberg H.C., Wieland S., Pembertron J., Steiger C., et al. Viral and immunological determinants of hepatitis C virus clearance, persistence and disease. PNAS 99 (2002) 15661-15668
14. Chen G.G., Lau W.Y., Lai P.B.S., Chun Y.S., Chak E.C.W., Leung B.C.S., et al. Activation of Kupffer cells inhibits tumor growth in a murine model system. Int J Cancer 99 (2002) 713-720
15. De Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69 (2001) 912-920
16. Der S.D., Zhou A., Williams B.R.G., and Silverman R.H. Identification of genes differentially regulated by interferon α, β or γ using oligonucleotide arrays. PNAS 95 (1998) 15623-15628
17. Radaeva S., Jaruga B., Hong F., Kim W.O., Fan S., Cai H., et al. Interferon-α activates multiple STAT signals and down-regulates c-met in primary human hepatocytes. Gastroenterology 122 (2002) 1020-1034
18. Ji X., Cheung R., Cooper S., Li Q., Greenberg H.B., and He X.S. Interferon alpha regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology 37 (2003) 610-621
19. Armbrust T., Nordmann B., Kreiβig M., and Ramadori G. C1Q synthesis by tissue mononuclear phagocytes from normal and from damaged rat liver: up-regulation by dexamethasone, down-regulation by interferon gamma and lypopolysaccharide. Hepatology 26 (1997) 98-106
20. Lachance P.E.D., and Chaudhuri E. Microarray analysis of developmental plasticity in monkey primary visual cortex. J Neurochem 88 (2004) 1455-1469
21. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnak A.K., Archer D.R., et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 (2000) 129-141
22. Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., and MacMicking J.D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261 (1993) 1445-1448
23. Kim S., and Ponka P. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J Biol Chem 275 (2000) 6220-6226
24. Jurado R.L. Iron, infections, and anemia of inflammation. Clin Infect Dis 25 (1997) 888-895
25. Knutson M.D., Vafa M.R., Haile D.J., and Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102 (2003) 4191-4197
26. Fell B., Smith A.M., Hill R.M., Parmar P.K., Coates L.C., Mezey E., et al. Characterisation of two serine protease inhibitors expressed in the pituitary gland. Arch Physiol Biochem 110 (2002) 26-33
27. Ishikawa H., Shinkai Y., Yagita H., Yue C.C., Henkart P.A., Sawada S., et al. Molecular cloning of rat cytolysin. J Immunol 143 (1989) 3069-3073
28. Strzelecka-Kiliszek A, Kwiatkowska K, Sobota A. Lyn and Syk kinases are sequentially engaged in phagocytosis mediated by Fc gamma. J Immunol 2002;169:6787-94.
29. Tordjmann T., Soulie A., Guettier C., Schmidt M., Berthou C., Beaugrand M., et al. Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis. Liver 18 (1998) 391-397
30. Feng L. Role of chemokines in inflammation and immunoregulation. Immunol Res 21 (2000) 203-210
31. Varley C.L., Armitage S., Hassanshahiraviz G., and Dickson A.J. Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes. Cytokine 23 (2003) 64-75
32. Ohteki T. Critical role for IL-15 in innate immunity. Curr Mol Med 2 (2002) 371-380
33. Wang X.Z., Zhang L.J., Li D., Huang Y.H., Chen Z.X., and Li B. Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4. World J Gastroenterol 9 (2003) 539-543
34. Kahlenberg J.M., and Dubyak G.R. Differing caspase-1 activation states in monocyte versus macrophage models of IL-1beta processing and release. J Leukoc Biol 76 (2004) 676-684
35. Zhong M.X., Kuziel W.A., Pamer E.G., and Serbina N.V. Chemokine Receptor 5 is dispensabel for innate and adaptive immune responses to Listeria monocytogenes infection. Infection and immunity 72 (2004) 1057-1064
36. Abdollahi A., Pisarcik D., Roberts D., Weinstein J., Cairns P., and Hamilton T.C. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J Biol Chem 278 (2003) 6041-6049
37. Grewal T.S., Genever P.G., Brabbs A.C., Birch M., and Skerry T.M. Best5: a novel interferon-inducible gene expressed during bone formation. FASEB J 14 (2000) 523-531
38. Sers C., Husmann K., Nazarenko I., Reich S., Wiechen K., Zhumabayeva B., et al. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Oncogene 21 (2002) 2829-2839
39. Oka T., Ouchida M., Koyama M., Ogama Y., Takada S., Nakatani Y., et al. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res 62 (2002) 6390-6394
40. Wagayama H., Shiraki K., Sugimoto K., Ito T., Fujikawa K., Yamanaka T., et al. High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases. Hum Pathol 33 (2002) 429-434
41. Scaffidi A.K., Petrovic N., Moodley Y.P., Fogel-Petrovic M., Kroeger K.M., Seeber R.M., et al. Alpha(v)beta(3) Integrin interacts with the transforming growth factor beta TGF beta type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts. J Biol Chem 279 (2004) 37726-37733